Geode Capital Management’s Azora Therapeutics AZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$86.4K Buy
21,546
+9,153
+74% +$39.4K ﹤0.01% 4096
2026
Q2
$31.7K Sell
12,393
-11,856
-49% -$23.5K ﹤0.01% 4314
2026
Q1
$43.4K Buy
24,249
+18,019
+289% +$63.4K ﹤0.01% 4347
2025
Q4
$34.3K Sell
6,230
-335
-5% -$2.71K ﹤0.01% 4302
2025
Q3
$58K Buy
6,565
+3,811
+138% +$37.1K ﹤0.01% 4258
2025
Q2
$20.8K Hold
2,754
– – ﹤0.01% 4356
2025
Q1
$43.7K Buy
2,754
+280
+11% +$5.78K ﹤0.01% 4224
2024
Q4
$62.5K Buy
2,474
+655
+36% +$17K ﹤0.01% 4203
2024
Q3
$45.4K Buy
1,819
+784
+76% +$20.4K ﹤0.01% 4283
2024
Q2
$29.8K Buy
+1,035
New +$39.1K ﹤0.01% 4391
2023
Q3
– Sell
-220
Closed -$28.6K – 4759
2023
Q2
$28.6K Hold
220
– – ﹤0.01% 4607
2023
Q1
$48.1K Hold
220
– – ﹤0.01% 4529
2022
Q4
$29K Hold
220
– – ﹤0.01% 4709
2022
Q3
$48K Buy
220
+3
+1% +$1.35K ﹤0.01% 4772
2022
Q2
$182K Buy
217
+1
+0.5% +$906 ﹤0.01% 4323
2022
Q1
$271K Buy
216
+9
+4% +$12.3K ﹤0.01% 4226
2021
Q4
$349K Buy
207
+53
+34% +$104K ﹤0.01% 4224
2021
Q3
$412K Buy
154
+13
+9% +$27.2K ﹤0.01% 4119
2021
Q2
$225K Buy
141
+16
+13% +$24.3K ﹤0.01% 4302
2021
Q1
$188K Hold
125
– – ﹤0.01% 4131
2020
Q4
$132K Hold
125
– – ﹤0.01% 4006
2020
Q3
$173K Hold
125
– – ﹤0.01% 3759
2020
Q2
$108K Hold
125
– – ﹤0.01% 3828
2020
Q1
$101K Hold
125
– – ﹤0.01% 3763
2019
Q4
$187K Hold
125
– – ﹤0.01% 3817
2019
Q3
$116K Hold
125
– – ﹤0.01% 3913
2019
Q2
$131K Hold
125
– – ﹤0.01% 3892
2019
Q1
$267K Buy
125
+103
+468% +$307K ﹤0.01% 3651
2018
Q4
$69K Buy
+22
New +$35.2K ﹤0.01% 3932

Other funds holding AZR

Geode Capital Management's AZR Position: Q3 2026 in Review

Geode Capital Management increased its Azora Therapeutics (AZR) stake by 74% in Q3 2026, buying an estimated $39.4K and bringing the position to 21,546 shares worth $86.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4096.

Geode Capital Management first reported a position in AZR in Q4 2018 and has held it in 29 quarters since. The position peaked at $412K in Q3 2021. 22 funds tracked by Wall St. Rank hold AZR as of Q3 2026.

  • Geode Capital Management held 21,546 shares of Azora Therapeutics worth $86.4K as of Q3 2026.
  • Geode Capital Management bought 9,153 Azora Therapeutics shares in Q3 2026, an estimated $39.4K.
  • Azora Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #4096 holding.
  • Geode Capital Management first reported a position in Azora Therapeutics in Q4 2018 and has held it in 29 quarters since.
  • Geode Capital Management's Azora Therapeutics position peaked at $412K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Azora Therapeutics as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.